Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.

@article{Schinnerling2015SkewingDC,
  title={Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.},
  author={Katina Schinnerling and Lilian Soto and Paulina A. Garc{\'i}a-Gonz{\'a}lez and Diego Catal{\'a}n and Juan Carlos Aguill{\'o}n},
  journal={Autoimmunity reviews},
  year={2015},
  volume={14 6},
  pages={517-27}
}
To date, the available options to treat autoimmune diseases such as rheumatoid arthritis (RA) include traditional corticoids and biological drugs, which are not exempt of adverse effects. The development of cellular therapies based on dendritic cells with tolerogenic functions (TolDCs) has opened a new possibility to efficiently eradicate symptoms and control the immune response in the field of autoimmunity. TolDCs are an attractive tool for antigen-specific immunotherapy to restore self… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 198 references

Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity

  • S Manicassamy, R Ravindran, J Deng, H Oluoch, TL Denning, SP Kasturi
  • Nat Med
  • 2009
Highly Influential
12 Excerpts

Similar Papers

Loading similar papers…